Wealthquest Corp Abb Vie Inc. Transaction History

Wealthquest Corp

$897 Million
Q3 2024

A detailed history of Wealthquest Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealthquest Corp holds 2,766 shares of ABBV stock, worth $497,880. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,766

Previous 6,261 55.82%

Holding current value

$497,880

Previous $1.07 Million 49.11%

% of portfolio

0.06%

Previous 0.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 21, 2024	SELL	$163.84 - $199.33 $572,620 - $696,658	-3,495 Reduced 55.82%	2,766 $546,000
Q2 2024 Aug 26, 2024	BUY	$154.79 - $180.76 $20,122 - $23,498	130 Added 2.12%	6,261 $1.07 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $136,965 - $156,059	-857 Reduced 12.26%	6,131 $1.12 Million
Q4 2023 Feb 15, 2024	BUY	$137.6 - $154.97 $28,620 - $32,233	208 Added 3.07%	6,988 $1.08 Million
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $53,302 - $61,705	-399 Reduced 5.56%	6,780 $1.01 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $238,650 - $296,984	1,801 Added 33.49%	7,179 $967,000
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $79,680 - $91,763	-551 Reduced 9.29%	5,378 $857,000
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $553 - $663	4 Added 0.07%	5,929 $958,000
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $53,684 - $61,572	-400 Reduced 6.32%	5,925 $795,000
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $415,887 - $528,729	-3,022 Reduced 32.33%	6,325 $968,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $42,434 - $53,692	395 Added 4.41%	9,347 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $61,818 - $70,173	581 Added 6.94%	8,952 $965,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $172,333 - $191,989	1,638 Added 24.33%	8,371 $942,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $22,096 - $24,325	216 Added 3.31%	6,733 $728,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $16,902 - $22,820	210 Added 3.33%	6,517 $698,000
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $63,229 - $74,210	-736 Reduced 10.45%	6,307 $552,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $5,282 - $7,068	72 Added 1.03%	7,043 $691,000
Q4 2019 Feb 18, 2020	BUY	$72.13 - $90.25 $19,835 - $24,818	275 Added 4.11%	6,971 $617,000
Q3 2019 Oct 18, 2019	SELL	$62.98 - $75.72 $220,115 - $264,641	-3,495 Reduced 34.29%	6,696 $507,000
Q2 2019 Jul 22, 2019	BUY	$65.7 - $83.98 $150,781 - $192,734	2,295 Added 29.07%	10,191 $741,000
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $8,716 - $10,259	-113 Reduced 1.41%	7,896 $636,000
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $623,500 - $768,944	8,009 New	8,009 $738,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthquest Corp, based on Form 13F filings with the SEC.

News

Stay updated on Wealthquest Corp with notifications on news.

Account

Wealthquest Corp Abb Vie Inc. Transaction History